Literature DB >> 25972904

The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis.

Joanna Raszeja-Wyszomirska1, Robert Kucharski2, Marta Zygmunt1, Krzysztof Safranow3, Tomasz Miazgowski4.   

Abstract

BACKGROUND: Osteoporosis occurs frequently in patients with chronic cholestatic liver diseases, yet data are scarce regarding the prevalence of osteoporosis and fragility fractures and their impact on Health-Related Quality of Life (HRQoL) in Primary Sclerosing Cholangitis (PSC).
OBJECTIVES: We aimed to assess Bone Mineral Density (BMD), physical activity and incidence of fragility fractures in patients with PSC. We also sought associations between prior fractures and HRQoL. PATIENTS AND METHODS: The study was performed on 33 patients (11 females, 22 males) aged 35.3 ± 13 years. HRQoL was assessed by Short Form (SF)-36, Primary Biliary Cirrhosis (PBC)-40 and PBC-27 questionnaires. BMD was measured by densitometry in the lumbar spine and hip. Physical activity was assessed by questionnaire.
RESULTS: In 32% of patients, BMD measured in the hip or spine was below 1.0 Standard Deviation. A history of fragility fractures (distal forearm and ribs) was reported in six patients (18%). In SF-36 assessment, patients with fractures had lower scores in the role functioning, general health and vitality domains and Physical Component Summary (PCS) than those without fractures. Prior fractures adjusted for gender and PSC duration were associated with lower PCS and Mental Component Summary (MCS) scores. Symptoms and fatigue (assessed by PBC) and prior fractures were inversely associated with MCS (P = 0.007).
CONCLUSIONS: In middle-aged subjects with PSC, we found a high rate of non-vertebral fractures and a moderately decreased BMD in lumbar spine and hip. Fragility fractures had an impact on physical and mental aspects of HRQoL.

Entities:  

Keywords:  Cholangitis, Sclerosis; Health; Osteoporosis; Quality of Life

Year:  2015        PMID: 25972904      PMCID: PMC4426354          DOI: 10.5812/hepatmon.25539

Source DB:  PubMed          Journal:  Hepat Mon        ISSN: 1735-143X            Impact factor:   0.660


  30 in total

1.  Cholestatic liver diseases and health-related quality of life.

Authors:  Z M Younossi; M L Kiwi; N Boparai; L L Price; G Guyatt
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

Review 2.  Risk factors and management of osteoporosis in inflammatory bowel disease.

Authors:  Laura E Targownik; Charles N Bernstein; William D Leslie
Journal:  Curr Opin Gastroenterol       Date:  2014-03       Impact factor: 3.287

3.  Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis.

Authors:  Maria Benito de Valle; Monira Rahman; Björn Lindkvist; Einar Björnsson; Roger Chapman; Evangelos Kalaitzakis
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-15       Impact factor: 11.382

4.  Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis.

Authors:  Mical S Campbell; Gary R Lichtenstein; Andrew D Rhim; Michael Pazianas; Thomas Faust
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

Review 5.  Quality of life in patients with osteoporosis.

Authors:  Paul Lips; Natasja M van Schoor
Journal:  Osteoporos Int       Date:  2004-12-18       Impact factor: 4.507

6.  Bone disease in patients with primary sclerosing cholangitis.

Authors:  Paul Angulo; Garfield A Grandison; Derek G Fong; Jill C Keach; Keith D Lindor; Einar Bjornsson; Alvaro Koch
Journal:  Gastroenterology       Date:  2010-10-16       Impact factor: 22.682

7.  A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis.

Authors:  Lorenzo Montali; Atsushi Tanaka; Paolo Riva; Hiroki Takahashi; Claudio Cocchi; Yoshiyuki Ueno; Massimo Miglioretti; Hajime Takikawa; Luca Vecchio; Alessandra Frigerio; Ilaria Bianchi; Roberta Jorgensen; Keith D Lindor; Mauro Podda; Pietro Invernizzi
Journal:  Dig Liver Dis       Date:  2010-02-16       Impact factor: 4.088

8.  Underreporting of vertebral fractures on routine chest radiography.

Authors:  N Kim; B H Rowe; G Raymond; H Jen; I Colman; S A Jackson; K G Siminoski; A M Chahal; D Folk; S R Majumdar
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

Review 9.  Primary sclerosing cholangitis.

Authors:  Gideon M Hirschfield; Tom H Karlsen; Keith D Lindor; David H Adams
Journal:  Lancet       Date:  2013-06-28       Impact factor: 79.321

10.  Estimated lean mass and fat mass differentially affect femoral bone density and strength index but are not FRAX independent risk factors for fracture.

Authors:  William D Leslie; Eric S Orwoll; Carrie M Nielson; Suzanne N Morin; Sumit R Majumdar; Helena Johansson; Anders Odén; Eugene V McCloskey; John A Kanis
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

View more
  8 in total

Review 1.  Osteoporosis across chronic liver disease.

Authors:  M Guarino; I Loperto; S Camera; V Cossiga; C Di Somma; A Colao; N Caporaso; F Morisco
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

2.  Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis: a comparison study with dual-energy X-ray absorptiometry.

Authors:  Sarah Keller; Harald Ittrich; Christoph Schramm; Ansgar W Lohse; Michael Amling; Gerhard Adam; Jin Yamamura
Journal:  Jpn J Radiol       Date:  2016-08-04       Impact factor: 2.374

Review 3.  Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges.

Authors:  Nicola Pugliese; Ivan Arcari; Alessio Aghemo; Andrea G Lania; Ana Lleo; Gherardo Mazziotti
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

4.  Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.

Authors:  James H Tabibian; Ahmad H Ali; Keith D Lindor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-05

Review 5.  Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review.

Authors:  Fatima Isa; Grace M Turner; Geetinder Kaur; Derek Kyte; Anita Slade; Tanya Pankhurst; Larissa Kerecuk; Thomas Keeley; James Ferguson; Melanie Calvert
Journal:  Health Qual Life Outcomes       Date:  2018-07-05       Impact factor: 3.186

6.  Quality of life in primary sclerosing cholangitis: a systematic review.

Authors:  Elena Marcus; Paddy Stone; Anna-Maria Krooupa; Douglas Thorburn; Bella Vivat
Journal:  Health Qual Life Outcomes       Date:  2021-03-20       Impact factor: 3.186

7.  Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review.

Authors:  Lea Ladegaard Grønkjær; Mette Munk Lauridsen
Journal:  JHEP Rep       Date:  2021-09-28

Review 8.  A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis.

Authors:  Claudiu Marinel Ionele; Adina Turcu-Stiolica; Mihaela Simona Subtirelu; Bogdan Silviu Ungureanu; George Ovidiu Cioroianu; Ion Rogoveanu
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.